391 related articles for article (PubMed ID: 11373409)
1. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock.
Tsuneyoshi I; Yamada H; Kakihana Y; Nakamura M; Nakano Y; Boyle WA
Crit Care Med; 2001 Mar; 29(3):487-93. PubMed ID: 11373409
[TBL] [Abstract][Full Text] [Related]
2. Low-dose vasopressin in the treatment of vasodilatory septic shock.
Malay MB; Ashton RC; Landry DW; Townsend RN
J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
[TBL] [Abstract][Full Text] [Related]
3. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.
Dünser MW; Mayr AJ; Ulmer H; Ritsch N; Knotzer H; Pajk W; Luckner G; Mutz NJ; Hasibeder WR
Anesth Analg; 2001 Jul; 93(1):7-13. PubMed ID: 11429329
[TBL] [Abstract][Full Text] [Related]
4. Effects of continuous vasopressin infusion in patients with septic shock.
Obritsch MD; Jung R; Fish DN; MacLaren R
Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors.
Erwin BL; Denaburg MA; Barker AB; McArdle PJ; Windham ST; Morgan CJ
Crit Care Med; 2017 Dec; 45(12):e1226-e1232. PubMed ID: 28991825
[TBL] [Abstract][Full Text] [Related]
6. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
[TBL] [Abstract][Full Text] [Related]
7. The Therapeutic Role of Vasopressin on Improving Lactate Clearance During and After Vasogenic Shock: Microcirculation, Is It The Black Box?
Barzegar E; Ahmadi A; Mousavi S; Nouri M; Mojtahedzadeh M
Acta Med Iran; 2016 Jan; 54(1):15-23. PubMed ID: 26853286
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of short-term vasopressin infusion during severe septic shock.
Patel BM; Chittock DR; Russell JA; Walley KR
Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
[TBL] [Abstract][Full Text] [Related]
9. Endocrinologic response to vasopressin infusion in advanced vasodilatory shock.
Dünser MW; Hasibeder WR; Wenzel V; Schwarz S; Ulmer H; Knotzer H; Pajk W; Friesenecker BE; Mayr AJ
Crit Care Med; 2004 Jun; 32(6):1266-71. PubMed ID: 15187504
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and metabolic effects of vasopressin infusion in children with shock.
Baldasso E; Ramos Garcia PC; Piva JP; Einloft PR
J Pediatr (Rio J); 2007 Nov; 83(5 Suppl):S137-45. PubMed ID: 18038019
[TBL] [Abstract][Full Text] [Related]
11. The role of vasopressin in vasodilatory septic shock.
Obritsch MD; Bestul DJ; Jung R; Fish DN; MacLaren R
Pharmacotherapy; 2004 Aug; 24(8):1050-63. PubMed ID: 15338853
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin Plasma Concentrations Are Not Associated with Hemodynamic Response to Exogenous Vasopressin for Septic Shock.
Yerke JR; Sacha GL; Scheraga RG; Culver DA; Abraham S; Torbic H; Lam SW; Ammar MA; Olman MA; Bauer SR
Pharmacotherapy; 2020 Jan; 40(1):33-39. PubMed ID: 31705703
[TBL] [Abstract][Full Text] [Related]
13. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
Hodge EK; Hughes DW; Attridge RL
Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
[TBL] [Abstract][Full Text] [Related]
14. Effects of vasopressin in septic shock.
Ruggiero MS
AACN Adv Crit Care; 2008; 19(3):281-7. PubMed ID: 18670203
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in perioperative anesthetic management update on the role of vasopressin and its effects on outcomes.
Udeh CI; Diaz-Gómez JL; Anthony D; Satyapriya A; Perez-Protto S; Hata JS
Curr Pharm Des; 2012; 18(38):6308-13. PubMed ID: 22762470
[TBL] [Abstract][Full Text] [Related]
16. Dobutamine compensates deleterious hemodynamic and metabolic effects of vasopressin in the splanchnic region in endotoxin shock.
Martikainen TJ; Uusaro A; Tenhunen JJ; Ruokonen E
Acta Anaesthesiol Scand; 2004 Sep; 48(8):935-43. PubMed ID: 15315609
[TBL] [Abstract][Full Text] [Related]
17. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series.
Holmes CL; Walley KR; Chittock DR; Lehman T; Russell JA
Intensive Care Med; 2001 Aug; 27(8):1416-21. PubMed ID: 11511958
[TBL] [Abstract][Full Text] [Related]
18. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study.
Avontuur JA; Tutein Nolthenius RP; van Bodegom JW; Bruining HA
Crit Care Med; 1998 Apr; 26(4):660-7. PubMed ID: 9559602
[TBL] [Abstract][Full Text] [Related]
19. Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport.
Morelli A; Lange M; Ertmer C; Broeking K; Van Aken H; Orecchioni A; Rocco M; Bachetoni A; Traber DL; Landoni G; Pietropaoli P; Westphal M
Shock; 2007 Nov; 28(5):530-5. PubMed ID: 17589379
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial.
Lauzier F; Lévy B; Lamarre P; Lesur O
Intensive Care Med; 2006 Nov; 32(11):1782-9. PubMed ID: 17019548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
